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Background: Apoptotic oligonucleosomal DNA degradation is mediated by DFF40/CAD endonuclease.
Results: Poor DFF40/CAD expression in the cytosol coupled to the caspase-dependent cytosolic processing of ICADL/S impair
oligonucleosomal DNA degradation in SK-N-AS cells.
Conclusion: Oligonucleosomal DNA fragmentation during apoptosis is directly correlated with adequate DFF40/CAD cyto-
solic levels.
Significance: Learning how DFF40/CAD works is crucial for understanding the relevance of apoptosis ending in cancer
development.
Apoptotic cell death is characterized by nuclear fragmenta-
tion and oligonucleosomal DNA degradation, mediated by the
caspase-dependent specific activation of DFF40/CAD endonu-
clease. Here, we describe how, upon apoptotic stimuli, SK-N-AS
human neuroblastoma-derived cells show apoptotic nuclear
morphology without displaying concomitant internucleosomal
DNA fragmentation. Cytotoxicity afforded after staurosporine
treatment is comparable with that obtained in SH-SY5Y cells,
which exhibit a complete apoptotic phenotype. SK-N-AS cell
death is a caspase-dependent process that can be impaired by
the pan-caspase inhibitor q-VD-OPh. The endogenous inhibi-
tor of DFF40/CAD, ICAD, is correctly processed, and dff40/cad
cDNA sequence does not reveal mutations altering its amino
acid composition. Biochemical approaches show that both
SH-SY5Y and SK-N-AS resting cells express comparable levels
of DFF40/CAD. However, the endonuclease is poorly expressed
in the cytosolic fraction of healthy SK-N-AS cells. Despite this
differential subcellular distribution of DFF40/CAD, we find no
differences in the subcellular localization of both pro-caspase-3
and ICAD between the analyzed cell lines. After staurosporine
treatment, the preferential processing of ICAD in the cytosolic
fraction allows the translocation of DFF40/CAD from this frac-
tion to a chromatin-enriched one. Therefore, the low levels of
cytosolic DFF40/CAD detected in SK-N-AS cells determine the
absence of DNA laddering after staurosporine treatment. In
these cells DFF40/CAD cytosolic levels can be restored by the
overexpression of their own endonuclease, which is sufficient to
make them proficient at degrading their chromatin into oligo-
nucleosome-size fragments after staurosporine treatment.
Altogether, the cytosolic levels ofDFF40/CADare determinants
in achieving a complete apoptotic phenotype, including oligo-
nucleosomal DNA degradation.
Apoptotic cell death is critical during embryogenesis and tis-
sue homeostasis in metazoans (1–3). A misbalance in this bio-
logical process also plays an important role in the development
of different human diseases, including cancer (4, 5). Apoptosis
is characterized by a set of morphological and biochemical
events, including shrinkage and fragmentation of the nucleus as
well as chromatin degradation (3). The execution of apoptotic
cell death is governed by caspases, a family of cysteine proteases
that, after activation by different pro-apoptotic stimuli, cleave
target cell substrates (6–9).DNAdegradation is considered one
of the hallmarks of apoptotic cell death (1) and usually occurs in
a two-step process. First, the chromatin is cleaved into
50–300-kb fragments, termed high molecular weight (HMW)6
DNA fragmentation. Subsequently, DNA is degraded into
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smaller fragments of oligonucleosomal size, known as low
molecular weight (LMW)DNA degradation and visualized as a
laddering pattern in an agarose gel electrophoresis (DNA lad-
der) (2).
The main nuclease responsible for DNA laddering during
apoptosis was first identified in humans and mice. The human
homologue has been named DFF40 (DNA fragmentation fac-
tor, 40-kDa subunit) or caspase-activated nuclease (CPAN),
whereas the mouse orthologue is known as caspase-activated
DNase (CAD) (10–12). In growing cells DFF40/CAD remains
inactive, associated with its chaperone and inhibitor, ICADL
(13), also known as DNA fragmentation factor, 45-kDa subunit
(DFF45) (12, 14). Two alternatively spliced isoforms of ICAD
have been described, the long (ICADL) and the short (ICADS)
variants, containing two caspase recognition sites at Asp117 and
Asp224 residues. DFF40/CAD activation occurs after caspase-3
processes both ICAD isoforms (12–14). The generation of the
knock-out mice for ICAD revealed that this protein acts as a
chaperone assisting CAD synthesis (15–17). Therefore, the
functional consequences of ICAD deficiency (absence of apo-
ptotic DNA fragmentation) have been attributed to the lack of
CAD synthesis.
Upon apoptotic insult, DFF40/CAD needs to be located in
the nucleus to degrade the chromatin. It has been described
that ICAD-CAD complex is found either in the cytosol (10, 18)
or in the nucleus (12, 19–22) of healthy cells. In this work we
show that DFF40/CAD protein can be detected in both the
cytosolic and the nuclear subcellular compartments of resting
cells. However, the levels of the endonuclease in each subcellu-
lar compartment are indeed a cell-specific feature. In this sense
we have detected that in cells displaying oligonucleosomal
DNA degradation upon staurosporine treatment (SH-SY5Y
cells), the endonuclease is located in both cytosol and nuclei.
However, when DFF40/CAD is not enriched in the cytosolic
fraction, cells are defective in the generation of DNA laddering
(SK-N-AS cells). To carry out its endonuclease function,
DFF40/CAD needs to be located in the same fraction where
ICAD is preferentially processed, the cytosolic fraction.
Increasing the cytosolic levels of DFF40/CAD in SK-N-AS cells
by overexpression of its own endonuclease restores the ability
to degrade DNA into LMW fragments. Altogether, our results
indicate that despite DFF40/CAD nuclear localization, resting
cells require a pool in the cytosol to achieve LMWDNA degra-
dation upon apoptotic insult.
EXPERIMENTAL PROCEDURES
Reagents—All chemicals were obtained from Sigma unless
otherwise indicated. The pan-caspase inhibitor q-VD-OPhwas
fromMPBiomedicals Europe (Illkirch, France). HumanTRAIL
(tumor necrosis factor-related apoptosis-inducing ligand)
(CYT-443) and human TNF (CYT-223) were obtained from
AbBcn S. L. (Barcelona, Spain). Anti-Fas (human, activating
antibody) (clone CH11) (05-201) was from Millipore Iberica
S.A.U. (Madrid, Spain). Cycloheximide was purchased from
VWR International Eurolab S.L. (Barcelona, Spain). Nocoda-
zole was fromMerck KGaA (Darmstadt, Germany). Antibodies
against pro-caspase-3 (9662; 1:2000), pro-caspase-7 (9492;
1:2000), and cleaved poly(ADP-ribose) polymerase (9542;
1:5000) were purchased from Cell Signaling Technology (Bev-
erly, MA). Antibodies against DFF40/CAD (AB16926, 1:500)
and -Fodrin (clone AA6) (MAB1622; 1:40,000) were obtained
from Millipore Iberica S.A.U. (Madrid, Spain). Antibodies
against pro-caspase-6 (clone 3E8) (M070–3; 1:2,000) and
DFF45/ICAD (clone 6B8) (M037–3; 1:40,000) were from MBL
(Naka-ku Nagoya, Japan). Anti-PKM2 antibody (H00005315-
A01; 1:1000) was from Abnova (Jhongli, Taiwan). Anti-Lamin
A/C (clone JOL2) (Ab40567; 1:2000) was from Abcam (Cam-
bridge, UK). Anti-p23 antibody (clone JJ3) (NB300-576;
1:10,000) was obtained from Novus Biological Europe, Inc
(Cambridge, UK). Anti-topoisomerase I (2012-4; 1:20,000) was
from TopoGEN, Inc. Secondary antibodies against mouse IgG
(A9044; 1:10,000) and rabbit IgG (A0545; 1:20,000) were pur-
chased from Sigma.
Cell Lines and Culture Procedures—Human SH-SY5Y, SK-
N-AS, SK-N-SH, IMR-5, IMR-32, LAI-5S, LAN-1, and SK-N-
BE(2) cell lines were routinely grown in 100-mm culture dishes
(BD Biosciences) containing 10 ml of Dulbecco’s modified
Eagle’s medium supplemented with penicillin/streptomycin
(100 units/ml and 100 g/ml, respectively) and 10% of heat-
inactivated fetal bovine serum (Invitrogen). Medium was rou-
tinely changed every 3 days. Cells were maintained at 37 °C in a
saturating humidity atmosphere containing 95% air and 5%
CO2. For the different experiments, cells were grown at the
adequate cell densities in culture dishes ormultiwell plates (BD
Biosciences) using the same culture conditions as described
above. Some neuroblastoma cell lines employed in this work
were generous gifts from Dr. M. Esteller and Dr. M. Berdasco
(Institut d’Investigacio´ Biome`dica de Bellvitge (IDIBELL), Bar-
celona, Spain).
Trypan Blue Exclusion Assays and Chromatin Staining with
Hoechst 33258—Trypan blue assays and nuclear morphology
by Hoechst 33258 staining were performed as previously
established in our laboratory (23). The cell nuclei were visu-
alized with a Nikon ECLIPSE TE2000-E microscope
equipped with epifluorescence optics under UV illumination
and a Hamamatsu ORCA-ER photographic camera. Uni-
formly stained nuclei were scored as stage I (partial chroma-
tin condensation in the absence of karyorrhexis) or stage II
(nuclear pyknosis and karyorrhexis) morphology.
Oligonucleosomal DNA Degradation Analysis and Quan-
tification—Oligonucleosomal DNA degradation analysis was
carried out as previously described (24). Extracted DNA was
analyzed in 1.8% agarose gel in 1mMEDTA, 40mMTris acetate,
pH 7.6, stained in 0.5 g/ml of ethidium bromide, and then
visualized using a Syngene Gene Genius UV transilluminator
equipped with a photographic camera.
The quantification of oligonucleosomal DNA fragments was
performed as previously described with some modifications
(25). Briefly, after the adequate treatments, 2  106 cells were
lysed by the addition of 300 l of DNA fragmentation lysis
buffer (0.1% Triton X-100, 20 mM EDTA, 5 mM Tris-HCl, pH
8.5). After the addition of polyethylene glycol (PEG) 8000 and
NaCl to a final concentration of 4% and 1 M, respectively, sam-
ples were placed on ice for 10 min and then centrifuged at
16,000 g for 10 min at room temperature. The supernatants
were removed and treated with proteinase K and DNase-free
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RNase A at a final concentration of 200 and 20 g/ml, respec-
tively. A third part of the supernatants was used to determine
the concentration of DNA by adding an equal volume of
Hoechst dye solution (0.2g/mlHoechst 33258 in PBS, pH 7.4)
to an aliquot (50 l) of the supernatant. After 20 min at room
temperature, fluorescence of the samples was determined at
360-nm excitation, 460-nm emission on a BIO-TEK Synergy
HTFluorometer. The remaining supernatantswere used to iso-
late and precipitate DNA as described for oligonucleosomal
DNA degradation analysis.
High Molecular Weight DNA Fragmentation—The proce-
dure employed for these experiments was the same as that
described by Barry and Eastman (26) with some modifications.
Briefly, 5  105 cells were seeded in 12-multiwell plates, and
after 24 h they were treated with 1 M STP for 6 h. Then cells
were centrifuged for 5 min at 500  g and washed once with
PBS. Meanwhile, 150 ml of 2% agarose in 1TBE (89mMTris-
base, 89 mM boric acid, 2 mM EDTA, pH 8.0) was poured into a
horizontal gel support (15  15 cm) with the comb at 3.5 cm
from one end. Once gelled, the portion of the gel placed 1 mm
above the comb was removed by cutting with a scalpel and
replaced with 50 ml of 1% agarose, 2% sodium dodecyl sulfate,
64 g/ml proteinase K in 1 TBE buffer. Before loading, each
pellet of cells was resuspended in 15 l of 1:1 sample buffer (10
mMTris-HCl, pH8.8, 50%glycerol, 0.1%bromphenol blue) plus
10 mg/ml RNase A. The gel was electrophoresed at room tem-
perature for 16 h at 45 V. After electrophoresis, the gel was
stained in 2 g/ml ethidium bromide for 2 h and washed twice
with distilled water for 30 min. DNA was visualized using a
SyngeneGeneGeniusUV transilluminator coupledwith a pho-
tographic camera.
Protein Extractions and Western Blotting—Approximately
1 106 cells/condition were detached from the 35-mm culture
dish, pelleted at 600 g for 5 min, and washed once with PBS.
Then cells were lysed for 15 min on ice with 50 l of Triton
buffer (50mMTris-HCl, pH 6.8, 1mMEDTA, 150mMNaCl, 1%
Triton X-100, 1 protease inhibitor mixture (Roche Applied
Science). The supernatants were clarified by centrifuging at
16,000 g for 5 min at 4 °C. Alternatively, cells were lysed with
100 l of SET buffer (10 mM Tris-HCl, pH 6.8, 150 mM NaCl, 1
mM EDTA, 1% SDS) and heated at 95 °C for 10 min to obtain
total protein extracts. The protein concentration in the super-
natants was quantified by a modified Lowry assay (DC protein
assay, Bio-Rad), and 15–30 g of protein were loaded in SDS-
polyacrylamide gels. The proteins were electrophoresed and
electrotransferred onto polyvinylidene difluoride (PVDF)
Immobilon-P membrane (Millipore Ibérica S.A. U) or Protran
nitrocellulose transfer membrane (Whatman GmbH, Dassel,
Germany). After blocking with Tris-buffered saline, 0.1%
Tween 20 containing 5% nonfat dry milk, the membranes were
probed with the appropriate specific primary antibodies and
incubated with the adequate secondary antibodies conjugated
with peroxidase. Finally, immunoblots were developedwith the
EZ-ECL chemiluminescence detection kit (Biological Indus-
tries, Kibbutz Beit-Haemek, Israel).
DEVD-directed Caspase Activity—Quantitative DEVD-like
activities in cell lysates were performed as previously described
(27). The resulting 96-multiwell microplates were incubated at
35 °C, and caspase activity wasmeasured after 7 h of incubation
in a BIO-TEK Synergy HT fluorimeter with an excitation filter
of 360 nm (40-nm bandwidth) and emission filter of 530 nm
(25-nm bandwidth).
Preparation of Cytosolic Extracts—Cytosolic extracts were
obtained by a modified protocol form previously described (27,
28). Cells were grown in 75-cm2 flasks and treated with 1 M
STP for 12 h or left untreated. Cells were collected and centri-
fuged at 200 g for 5 min, washed with PBS, resuspended in 5
volumes of cytosolic extraction buffer (20mMTris-HCl, pH 7.4,
10 mM KCl, 2 mM MgCl2, 1 mM DTT, 0.5 mM EGTA, 2.5%
glycerol, 0.5% Igepal CA-630), and swelled at 4 °C for 15 min.
The lysates were centrifuged for 5 min at 600  g in a micro-
centrifuge at 4 °C to remove the nuclei, and the supernatants
were centrifuged again at 16,000 g for 15min and then quan-
tified using the Bio-Rad protein assay Lowry-based method.
Preparation of SH-SY5Y and SK-N-AS Nuclei and Reconsti-
tution of the Cell-free System—Nuclei were obtained as previ-
ously described (27). Aliquots of 5  107 nuclei/ml were pre-
pared and kept at80 °C until use.
To reconstitute the system, cytosolic extracts and purified
nuclei from the different conditions were adequately com-
bined. Thus, 150 g of protein from cytosolic extracts treated
with 1.5 g of RNase A for 10 min at 25 °C and 6 105 nuclei
were incubated at 37 °C for 2 h in a 2 reaction buffer (40 mM
Tris-HCl, pH 7.5, 20mMKCl, 100mMNaCl, 8mMMgCl2, 2mM
DTT, 1 mM EGTA, 0.2% Triton X-100, 1 protease inhibitor
mixture) in a 100-l reaction. Reactions were stopped by add-
ing 5mMEDTA.Nucleiwere centrifuged for 15min at 16,000
g (4 °C), and the pellet was washed once with cytosolic extrac-
tion buffer. DNA was extracted with phenol:chloroform:iso-
amyl alcohol (25:24:1), and ethanol precipitation and DNA lad-
dering was analyzed in a 1.8% agarose gel.
Chromatin Isolation—The subfractionation protocol was
performed as previously described byMéndez and Stillman (29)
with some modifications. Cells were seeded in 35-mm culture
dishes and treated with 1 M STP for 6 h. Then cells were
collected with their medium, centrifuged at 500 g for 5 min,
washed once with PBS, and resuspended in 3 volumes (60l) of
buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2,
0.34M sucrose, 10% glycerol, 1mMDTT, 0.1%TritonX-100, 1
protease inhibitor mixture). Cells were incubated for 5 min on
ice, and nuclei were collected by low speed centrifugation (4
min, 1300 g, 4 °C). The supernatants were further clarified by
high speed centrifugation (20 min, 20,000  g, 4 °C) obtaining
the cytosolic (C) fraction. The resulting pellets were washed
twice in buffer A without Triton X-100 and then lysed in 60 l
of Triton buffer (50mMTris-HCl, pH 6.8, 1mM EDTA, 150mM
NaCl, 1% Triton X-100, 1 protease inhibitor mixture). Then,
the supernatants were clarified by centrifuging at 16,000 g for
5 min at 4 °C to obtain the nuclear (N) fraction.
Alternatively, the nuclear fractions were resuspended in 60
l of buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mMDTT, supple-
mentedwith 1 protease inhibitors) and kept on ice for 15min.
Then samples were clarified by centrifugation (4min, 1700 g,
4 °C). Supernatants were considered the nucleoplasmic (N1)
fractions. The pellets obtained were washed once in buffer B
and centrifuged again under the same conditions. The final
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resulting pellets were resuspended in 60 l of SET buffer and
heated at 95 °C for 10 min, obtaining the chromatin-enriched
(N2) fractions. The protein concentration in the different frac-
tions recovered was determined by the Bio-Rad protein assay
Lowry-based method, and 15–20 g of protein from each frac-
tion were loaded in SDS-polyacrylamide gels.
Sequencing of DFF40/CAD from SK-N-AS Cells—mRNAwas
isolated from untreated SK-N-AS cells using the RNeasy kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions, employing for the extraction the RLN buffer (50
mMTris-HCl, pH 8.0, 140mMNaCl, 1.5mMMgCl2, 0.5% Igepal
CA-630, 1000 units/ml RNase inhibitor, 1 mM DTT). Total
RNA (2 g) from SK-N-AS was reverse-transcribed
(Trasnscriptor First Strand cDNA synthesis kit, Roche Applied
Science) using 10 pmol of random hexamer primers or the spe-
cific downstream primer (CAD-R; see below) for 30 min at
65 °C. cDNA obtained (2 l) was amplified by PCR in an
Applied Biosystem thermal cycler 2720with 300 nM concentra-
tions of each primer. The PCR conditions were 95 °C for 20 s,
56 °C for 10 s, and 70 °C for 24 s, repeated 30 cycles, in 1.5 mM
MgSO4, 200 nM each dNTP, and 1 unit of KODHot Start DNA
polymerase (Merck KGaA). Primers used were CAD forward
(5-CAGAGGGCTTGAGGACAT-3) and CAD reverse (5-
TCAGGCCTCAAACAAAGACCAGGA-3), amplifying a
band of 1080 bp corresponding to the whole ORF of human
DFF40/CAD (GenBankTM accession number NM_004402).
FIGURE 1.Analysis of apoptotic hallmarks in different humanneuroblastoma-derived cell lines uponSTP treatment. Eight different neuroblastoma cell
lines (SK-N-SH, SH-SY5Y, IMR-32, IMR-5, LAN-1, LAI-5S, SK-N-AS, and SK-N-BE(2)) were left untreated (Control) or treated with 1 M STP for 24 h. A, micropho-
tographs using a phase contrastmicroscopy show themorphological appearance of the different cell lines after the indicated treatment. The insets are higher
magnifications of the cells framed in the images. The bars indicate 40m. B, shown is themorphological appearance of the nuclei stainedwithHoechst 33258.
The right panels are highermagnifications of the cells framed in themiddle panels. The bars indicate 40m. C, shown is quantification of cell death by counting
stage I or stage II nuclear morphology according to “Experimental Procedures.” Values are expressed as the means  S.E. D, genomic DNA analysis of the
different cell lines by conventional agarose gel electrophoresis and the subsequent ethidium bromide staining is shown. E, shown is a table summarizing the
percentageof chromatin-packaged stageobserved in thedifferent cell lines and its correlationwith their ability todegrade theirDNA into LMWsize fragments.
Note that SK-N-AS cells show stage II nuclear morphology in the absence of a DNA laddering pattern.  means 25%;  means 26–50%;  means
51–75%,means76% of nuclei in stage I and/or stage II apoptotic nuclear morphology.
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The PCRproducts were automatically sequenced in both direc-
tions in a 3130XL genetic analyzer (Applied Biosystems).
Cloning and Transfection of DFF40/CAD—DFF40/CAD full-
length open reading frame cDNAsequence fromSK-N-AS cells
was subcloned into the pcDNA3 vector (Invitrogen). The con-
struct was named pcDNA3-DFF40/CAD and transfected in
SK-N-AS cells using Attractene Transfection Reagent (Qiagen)
according to the manufacturer’s instructions. Stably trans-
fected cells were selected for a month in the presence of 1
mg/ml G-418 (Geneticin) (Invitrogen) and were used as a pool.
DFF40/CAD overexpression was assessed by Western blot
analysis.
RESULTS
Human Neuroblastoma-derived Cell Lines Show Distinct
Apoptotic Nuclear Phenotypes upon Staurosporine Treatment—
We previously reported the existence of two human neuroblas-
toma-derived cell lines, IMR-5 and IMR-32, cells that undergo a
non-canonical apoptotic cell death upon apoptotic insult (30).
This kind of cell death, although caspase-dependent, was char-
acterized by the absence of both nuclear stage II apoptoticmor-
phology (condensation and fragmentation of the cell nuclei)
andoligonucleosomalDNA fragmentation (27). In thisworkwe
evaluated the morphological appearance of the nuclei and the
ability of eight well established human neuroblastoma-derived
cells to degrade their DNA into nucleosomal units when chal-
lenged with STP. As shown in Figs. 1, A and B, all cell lines
tested undergomorphological changes when treated with 1M
STP for 24 h. Comparedwith untreated cells, the addition of the
alkaloid to the culture media provokes cell shrinkage (Fig. 1A)
and an abnormal nuclear morphology (Fig. 1B). However,
Hoechst-stained chromatin from STP-treated cells revealed
distinct nuclear traits regarding the cell line used.We observed
FIGURE 1—continued
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two different types of abnormal nuclei; one of them displayed
classical apoptotic nuclei, i.e. highly condensed chromatin
and karyorrhexis (in SK-N-SH, SH-SY5Y, LAN-1, SK-N-AS,
and SK-N-BE(2) cells), whereas the other presented a partially
packaged chromatin (or stage I of apoptotic nuclear morphol-
ogy) and no evidence of karyorrhexis (in IMR-5, IMR-32, and
LAI-5S) (Fig. 1B).
Despite Presence of Apoptotic Nuclear Morphology and
HMW DNA Degradation, SK-N-AS Cells Are Not Able to
Hydrolyze Their Chromatin into LMW Fragments upon Apo-
ptotic Stimuli—The analysis of the DNA integrity revealed that
STP-treated cell lines displaying stage I of nuclear morphology
did not degrade their DNA into nucleosomal size fragments
(Fig. 1D). As shown in Figs. 1,C andD, most of the cell lines that
underwent typical nuclear traits of apoptotic cell death were
also able to degrade theirDNA into internucleosomal-size frag-
ments. Interestingly, STP did not induce DNA laddering in SK-
N-AS cells (Fig. 1D) even thoughmost of themdisplayed typical
apoptotic nuclear morphology (Fig. 1C). Data summarized in
Fig. 1E illustrate that apoptotic cells, which preferentially show
stage II nuclearmorphology, are also able to degrade their chro-
matin into oligonucleosomal fragments, with the exception of
SK-N-AS cells. This peculiarity of SK-N-AS cells was also
observed when other apoptotic stimuli were employed, includ-
ing activators of the intrinsic pathway (e.g. camptothecin,
nocodazole, or paclitaxel) (supplemental Fig. S1) as well as
inducers of the extrinsic pathway (i.e.CH11 (CD95/Fas agonist
antibody), TNF-, or TRAIL) (supplemental Fig. S2). To fur-
ther confirm the inability of SK-N-AS cells to generate oligo-
nucleosomal DNA degradation, we used a PEG-based bio-
chemical approach that preferentially allows the recovery of
medium-small pieces of nucleotides, such as the internucleo-
somal-size fragments of DNA (Ref. 25 and Fig. 2B), to be sub-
sequently quantified (Fig. 2A). To control the specificity of this
methodology, we took advantage of the intrinsic proprieties
characterizing SH-SY5Y and IMR-5 cells, which degrade or not
their DNA into LMW size fragments, respectively (27). In this
sense, SK-N-AS and IMR-5 cells showed a comparable quanti-
tative profile of DNA degradation after a time-course of STP
treatment (Fig. 2A). This is in agreement with the fact that both
cell lines, although degrading their chromatin into HMW size
fragments, did not displayDNA laddering (Ref. 31 and Figs. 2,B
and C). Although LMW fragments were not evidenced in both
SK-N-AS and IMR-5 cells (Fig. 2B), as depicted in Fig. 2A, STP
induced a peak of DNA fragmentation after 6 h, correlating
with the presence of HMW DNA degradation (Fig. 2C). How-
ever, at this time of treatment, SH-SY5Y cells showed a signif-
icant increase in the amount of fragmented DNA compared
with SK-N-AS or IMR-5 cells (Fig. 2A). This increase was asso-
ciated with the presence of LMW DNA fragmentation in
SH-SY5Y apoptotic cells (Fig. 2B). These results corroborate a
failure of SK-N-AS cells to degrade their DNA into oligo-
nucleosome-size fragments despite the ability to display stage II
apoptotic nuclear morphology.
SK-N-AS Cells Undergo Caspase-dependent Cell Death after
STP Treatment with Proper Activation of Caspase-3 and ICAD
Processing—It is well accepted that DFF40/CAD is the main
endonuclease responsible for the DNA hydrolysis into LMW
FIGURE 2. SK-N-AS cells degrade their DNA into HMW but not into LMW
fragments. A, quantification of LMW-fragmented DNA in SK-N-AS, SH-SY5Y,
and IMR-5 cells in a time-course experiment (3, 6, and 12 h) with 1 M STP.
Quantification was carried out as described under “Experimental Proce-
dures.” The fluorescence values acquired were expressed as arbitrary units
(F.A.U., fluorescence arbitrary units). All experiments were repeated at least
three times. Values are expressed as the means S.E. Student’s t tests were
used to determine the statistical significance. p 0.01 was considered to be
significant. B, genomic DNA analysis of the samples obtained in A is shown.
C, HMW fragmentation of the DNA in SH-SY5Y, SK-N-AS, and IMR-5 cells left
untreated (0) or treated with 1 M STP for 6 h is shown.
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size fragments during apoptosis (10, 12, 32). As shown in Fig.
3A, SK-N-AS cells expressed DFF40/CAD, maintaining the
protein levels after 24 h in the presence of STP. To look in
greater depth at the molecular mechanisms involved in the cell
death process induced by STP in SK-N-AS cells, we analyzed
the activation status of caspases. A failure in the activation of
these proteases could explain the defectiveness of SK-N-AS
cells in degrading their DNA into LMW fragments. In this
regard, STP induced a caspase-dependent cell death as the
addition of q-VD-OPh, a broad pan-caspase inhibitor, com-
pletely abrogated caspase activity (Fig. 3B) and, therefore, cell
death (Fig. 3C). In addition, executioner pro-caspases, i.e. pro-
caspase-3, -6, and -7, were processed into their respective sub-
units (Fig. 3D). This processing was avoided by the addition of
q-VD-OPh to the culture media (Fig. 3D). Moreover, STP
induced the proteolysis of general, e.g. poly(ADP-ribose)
polymerase, as well as specific caspase substrates (Fig. 3E).
Hence, caspase-3 cleaved -fodrin (-spectrin), giving a 120-
kDa fragment (27), caspase-6 processed laminA/C into 47- and
37-kDa fragments, respectively (33), and caspase-7 proteolyzed
p23 co-chaperone, generating a 17-kDa fragment (34) (Fig. 3E).
Finally, and according to the results obtained, q-VD-OPh
impaired the proteolysis of all caspases substrates tested (Fig.
3E). Having discarded a general defect in the activation of the
executioner caspases, we focused on the minimal components
required for oligonucleosomal DNA fragmentation, the
caspase-3-ICAD-DFF40/CAD axis (14). As shown in Fig. 4A,
we observed the activation of caspase-3 during a time-course of
STP treatment. This strictly correlated with the processing of
ICAD, DFF45/ICADL (long), and DFF35/ICADS (short) iso-
forms into their respective fragments.Moreover, the p11C-ter-
minal fragment, resulting from caspase-3-mediated cleavage of
DFF45/ICADL at the residue Asp224, was soon observed at 2 h
of treatment (Fig. 4A). The generation of this p11 fragment has
been proposed as the determinant for the proper release of
DFF40/CAD from its chaperone (35). Of note, p11 detection
was evidenced throughout the time of STP treatment in a
period in which oligonucleosomal DNA hydrolysis should take
place (Figs. 2B and 4A). In addition to that, DFF40/CADprotein
levels remained unaltered during the time of STP treatment
(Fig. 4A). To exclude a potential mutation in the dff40/cad gene
of SK-N-AS cells affecting its function, the cDNA correspond-
ing to the ORF of the endonuclease was obtained and entirely
sequenced in both directions. The results showed a wild-type
sequence with no mutations affecting the amino acid composi-
tion. However, compared with the human DFF40/CAD nucle-
otide consensus sequence from the NCBI nucleotide data base
(NCBI reference sequence NM_004402.2), we observed two
silent polymorphic variants corresponding to the 531 and 954
nucleotides of the DFF40/CAD coding sequence (Fig. 4B). This
polymorphic combination has been previously reported by
Wang and co-workers (12) after cloning and sequencing the
dff40 gene from HeLa cells.
Lack of DNA LMW Fragmentation in SK-N-AS Cells Is Not
Due Either to Non-nuclear DFF40/CAD Sublocalization or
Inherent Refractoriness of Their Chromatin to Be Degraded—
Given that the apoptotic function of DFF40/CAD is nuclear,
one possible explanation of the defect described for SK-N-AS
cells could rely on a non-nuclear sublocalization of the endo-
nuclease in dying cells. For this reason,we isolated cytosolic and
nuclear fractions from SH-SY5Y or SK-N-AS cells in the pres-
ence or absence of STP. Fig. 5A shows that, despite a differential
distribution ofDFF40/CAD in the cytosolic fractions, the endo-
nuclease was found in the nuclear fractions of both SK-N-AS
and SH-SY5Y cells either in untreated or STP-treated cells. At
this point we thought the refractoriness of SK-N-AS cells to
degrade their DNA into oligonucleosomal fragments could rely
on the chromatin structure, affecting the endonuclease acces-
sibility to the internucleosomal sites (36). For this reason we
performed cell-free assays employing non-treated SK-N-AS
FIGURE3.STP-inducedapoptosis inSK-N-AScells is a caspase-dependent
process.A, SK-N-AS cells were left untreated () or treated () for 24 hwith 1
M STP. Total extracts were obtained, and DFF40/CAD protein levels were
analyzed by Western blot. B and C, SK-N-AS cells were left untreated (UT) or
treated with 1 M STP alone or in the presence of the pan-caspase inhibitor
q-VD-OPh (20 M) (STP/QVD). DEVD-like activity (B) or cell viability by trypan
blue exclusion assay (C) was performed after 24 h of treatment. D and E,
SK-N-AS cells were left untreated () or treated () with 1 M STP alone or
plus q-VD-OPh (20 M) for 6 h. Pro-caspase-3, -6, and -7 processing in their
active fragments (D) and cleavage of poly(ADP-ribose) polymerase (PARP
(cleaved)), -Fodrin, lamin A/C, and p23 co-chaperone (E) were analyzed by
Western blot. The apparent molecular mass of the specific fragments is indi-
cated on the right of the panels. The membranes were stained with naphthol
blue (NB) to assess equal loading. A.U., fluorescence arbitrary units.
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isolated nuclei that were incubated with cytoplasmic extracts
from either untreated or STP-treated SK-N-AS or SH-SY5Y
cells. As shown in Fig. 5B, chromatin of isolated SK-N-AS
nuclei was digested into oligonucleosomal DNA fragments
when incubated with cytoplasmic extracts from STP-treated
SH-SY5Y cells. Nevertheless, the cytoplasm from STP-treated
SK-N-AS cells, displaying a DEVDase activity comparable with
that obtained in STP-treated SH-SY5Y cytoplasmic extracts
(Fig. 5C), failed to generate a DNA laddering pattern (Fig. 5B).
The inability of STP-treated SK-N-AS cytoplasm to degrade
DNA was due neither to an absence of DFF40/CAD protein
(Fig. 5D, upper panel) nor to an impairment in ICAD process-
ing (Fig. 5D,middle panel). Moreover, the detection of the 120-
kDa fragment of -fodrin in the cytoplasmic fractions from
FIGURE 4.Caspase-3/ICAD/CADaxis is properly activated in STP-treated SK-N-AS cells.A, protein extracts fromSK-N-AS cells treatedwith 1M STP for the
indicated timeswere analyzed byWestern blotting to assess caspase-3 activation (upper panel). Themembranewas re-probedwith amonoclonal antibody to
analyze thecleavageof ICAD (middlepanel) and subsequentlywithanantibodyagainstDFF40/CAD (lowerpanel). Thebandscorresponding to theunprocessed
proteins or the specific fragments are indicated on the right of the panel. Protein loading was assessed by staining the membranes with naphthol blue (NB).
B, shown are PCR products of dff40/cad from SK-N-AS cells amplified by either random hexamers (RH) or a specific reverse primer (R) (see “Experimental
Procedures”) (upper panel) andcDNAsequencing (lower scheme). Thedataobtained reveal two silentpolymorphisms comparedwith thenucleotide consensus
sequence for human dff40/cad gene (NCBI reference sequence NM_004402.2) at 531 (G to A) and 954 (A to G) nucleotides of the coding sequence (framed in
red boxes in the lower scheme).MW, molecular weight marker.
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STP-treated SK-N-AS cells by Western blot indicated that
caspase-3 was properly activated (Fig. 5D, lower panel).
Cytosolic Levels of DFF40/CAD Determine Refractoriness of
SK-N-AS Cells to Degrade DNA into LMW Size Fragments—At
this point, DFF40/CAD was found in the nuclear fraction of
both cell lines (Fig. 5A). However, SK-N-AS chromatin was
degraded into LMW fragments in a cell-free assay only when
extracts from STP-treated SH-SY5Y cells were employed (Figs.
5B). We then sought to analyze whether DFF40/CAD of SK-
N-AS cells associates with the chromatin upon STP treatment.
For this purpose we proceeded with amodified protocol from a
chromatin binding assay previously developed by Méndez and
Stillman (29). We obtained a chromatin-nuclear matrix frac-
tion (N2 in Fig. 6). As expected, DFF40/CAD was evidenced in
the chromatin-enriched fraction of SH-SY5Y cells treated with
STP (Figs. 6, A and B). However, the endonuclease was not
recovered in the chromatin-enriched fraction of SK-N-AS cells
upon apoptotic stimulus (Fig. 6A). Taking advantage of the sub-
fractionation method employed, besides the C and N2, we
obtained one additional fraction corresponding to the nucleo-
plasmic (N1) fraction. As can be observed in Figs. 5A (for the
cytosolic (C) fractions) and 6A (for both, cytosolic (C) and
nucleoplasmic (N1) fractions), we found evidence that DFF40/
CAD was recovered in both fractions in untreated SH-SY5Y
cells. However, in non-treated SK-N-AS cells, DFF40/CADwas
barely detected in the cytosolic fraction (Figs. 5A and 6A) but
enriched in the nucleoplasmic fraction (Fig. 6A). To verify the
purity of cytosolic and chromatin-enriched fractions, we ana-
lyzed the distribution of PKM2, a cytosolic protein kinase
involved in cell metabolism, and topoisomerase I, respectively
(Fig. 6A, middle and lower panels). As shown in Fig. 6B, we
corroborated that DNA is mainly purified in the chromatin-
enriched fraction after extracting from the different fractions
obtained. Some traces of DNA, probably fragmented DNA,
were only detected in the STP-treated cytosolic (C) fraction of
SH-SH5Y cells. As stated earlier, although DFF40/CAD levels
were comparable between nucleoplasmic (N1) fractions of
SH-SY5Y- and SK-N-AS-growing cells, we found a differential
recovery of the endonuclease in their respective cytosolic (C)
fractions (Figs. 5A and 6A). We, therefore, sought to determine
FIGURE 5. Despite DFF40/CAD nuclear protein levels being comparable
between SH-SY5Y and SK-N-AS cells, only the cytoplasm from STP-
treated SH-SY5Y cells generate DNA laddering in isolated nuclei of SK-
N-AS cells. A, SK-N-AS (SK) and SH-SY5Y (SH) cells treated () or not () with
1M STP for 6 hwere subjected to a biochemical subfractionation procedure
to separate the cytosolic (C) from the nuclear (N) fractions. Protein extracts
were quantified, loaded onto a polyacrylamide gel, electrotransferred to
PVDF membranes, and incubated with an anti-DFF40/CAD antibody (upper
panel). Membranes were re-probed with an anti-PKM2 (middle panel) and an
anti-topoisomerase I (TOPO I, lower panel) antibody to verify the purity of the
cytosolic and nuclear fractions, respectively. B, C, andD, shown is the cell-free
system assay. Cytoplasmic cell lysates were obtained from SH-SY5Y (SH) or
SK-N-AS (SK) cells treated () or not () with 1M STP for 12 h. Isolated nuclei
from untreated SK-N-AS cells were incubated for 2 h at 37 °C with 150 g of
the different cytoplasmic extracts. Then, nuclei were collected, and DNAwas
purified and analyzed by conventional agarose gel electrophoresis and
ethidium bromide staining (B). After the cell-free system reaction, aliquots
were taken, and quantitative DEVDase assay (C) or DFF40/CAD, ICAD, and
-Fodrin detection byWestern blot (D) were performed. In C, DEVDase activ-
ity was carried out by incubating 25g of extracts with Ac-DEVD- aminofluo-
romethylcoumarin for 7 h in the fluorimeter. Thedata obtained are expressed
as arbitrary units. Protein loading in D was assessed by staining the mem-
brane with naphthol blue (NB). A.U., fluorescence arbitrary units.
FIGURE 6.DFF40/CAD is not detected in the chromatin-enriched fraction
of SK-N-AS cells uponSTP treatment.A, SK-N-AS (SK) and SH-SY5Y (SH) cells
were treated () or not () with 1MSTP for 6 h. After that,weperformed the
biochemical fractionations as described in Fig. 5A. From the nuclear (N in Fig.
5A) fraction obtained,we further separated the chromatin-enriched (N2) frac-
tion from the nucleoplasmic (N1) fraction, and DFF40/CAD protein was ana-
lyzed byWestern blot (upper panel). PKM2 (middle panel) and topoisomerase
I (TOPO I, lower panel) were run as cytosolic and nuclear protein markers,
respectively. B, genomic DNA analysis of the different fractions obtained in A
was achieved by conventional agarose gel electrophoresis and subsequent
ethidiumbromide staining. Note that DNA ismainly observed in the N2 chro-
matin-enriched fraction in both cell lines.
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whether DFF40/CAD recovered in the chromatin-enriched
fraction from STP-treated SH-SY5Y cells actually comes from
its cytosolic pool. As shown in Fig. 7A, the levels ofDFF40/CAD
detected in the chromatin-enriched (N2) fraction of STP-
treated SH-SY5Y cells increased in a dose-dependent manner.
This correlated with a decrease in the amounts of DFF40/CAD
observed in the cytosolic (C) fraction (Fig. 7B), whereas the
endonuclease levels remained unaltered in the nucleoplasmic
(N1) fraction (Fig. 7C).
Taken together, the results indicate that DFF40/CAD that
accumulates into the chromatin-enriched fraction upon STP
treatment is derived from the cytosolic rather than the nucleo-
plasmic pool in SH-SY5Y cells. In STP-treated SK-N-AS cells,
the lack of DFF40/CAD in the chromatin-enriched fraction
could be explained by a problem in the chromatin binding
properties of the endonuclease. However, after 6 h of treatment
employing a higher concentration of the alkaloid (8 M),
DFF40/CAD was detected in the chromatin-enriched (N2)
fraction (Fig. 8A). This enrichment correlated with the disap-
pearance of DFF40/CAD from the cytosolic fraction (Fig. 8A).
Interestingly, even if DFF40/CAD was located at the chroma-
tin-enriched fraction after 6 h with 8 M STP, SK-N-AS cells
were still defective at degrading their DNA into oligonucleo-
some-size fragments (Fig. 8A). We then sought to corroborate
that DFF40/CAD cytosolic levels in untreated cells were deter-
minant in promoting oligonucleosomal DNA fragmentation
after STP treatment. For this purpose we augmented the
DFF40/CAD levels in SK-N-AS cells by overexpressing their
own endonuclease. As shown in Fig. 8B, the protein levels of
DFF40/CADwere efficiently increased in the cytosolic fraction
recovered fromSK-N-AS cells that were stably transfectedwith
the endonuclease (SK-N-AS-DFF40/CAD) comparedwith cells
that were stably transfected with the empty vector (SK-N-AS-
Neo). After 1 M STP treatment, DFF40/CAD was only
detected in the chromatin-enriched (N2) fraction from SK-N-
AS-DFF40/CAD cells correlating with the presence of oligo-
nucleosomal DNA fragments (Fig. 8B).
To explain the need for a specific pool of DFF40/CAD to
degrade DNA into LMW fragments, we analyzed the activation
FIGURE 7. DFF40/CAD detected in the chromatin-enriched fraction of
STP-treated SH-SY5Y cells comes from the cytosolic pool of the endonu-
clease. A, SH-SY5Y cells were treated with different concentrations of STP (0,
0.25, 0.5, 1, 2, 4, 8 M) for 6 h, and then cells were fractionated to obtain the
chromatin-enriched or N2 (A), the cytosolic or C (B), and the nucleoplasmic or
N1 (C) fractions. DFF40/CAD protein detection was performed by Western
blot in the different fractions obtained. PKM2 (middle panel) and topoisomer-
ase I (TOPO I, lower panel) were run as cytosolic and nuclear protein markers,
respectively.
FIGURE 8. The lack of DNA laddering in STP-treated SK-N-AS cells is not
due to a defect in the translocation of DFF40/CAD to the chromatin-en-
riched fraction but determined by the cytosolic levels of the endonu-
clease.A, SK-N-AS (SK) andSH-SY5Y (SH) cellswere treated () or not ()with
8 M STP for 6 h. Then cells were fractionated to obtain the cytosolic (C) and
the chromatin-enriched (N2) fractions. DFF40/CAD protein was assessed in
the cytosolic (C) and the chromatin-enriched fraction (N2). Otherwise, DNA
was extracted and analyzed by conventional agarose gel electrophoresis to
verify the oligonucleosomal DNA degradation. B, SK-N-AS cells stably trans-
fected with empty pcDNA3 (Neo) or pcDNA3-DFF40/CAD (CAD) plasmids
were treated with 1 M STP () or left untreated () for 6 h. Cells were frac-
tionated toobtain the cytosolic (C) and the chromatin-enriched (N2) fractions,
and DFF40/CAD protein was assessed by Western blot. Alternatively, DNA
was extracted and analyzed by conventional agarose gel electrophoresis to
analyze the DNA laddering. Note that only DFF40/CAD overexpressing cells
display a DNA laddering pattern upon STP treatment. PKM2 (middle panel)
and topoisomerase I (TOPO I, lower panel) were run as cytosolic and nuclear
protein markers, respectively.
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of caspase-3 and the processing of ICAD in the different
biochemical fractions obtained. As depicted in Fig. 9, pro-
caspase-3 and ICADL/S showed a preferential localization in the
cytosolic (C) fraction in both untreated SH-SY5Y and SK-N-AS
cells. After STP treatment, the caspase-mediated processing of
ICADL/Swas observed in the cytosolic fraction in both cell lines,
correlating with the detection of the active p17 subunit of
caspase-3 (Fig. 9).
Altogether, our results show that cells require certain levels
of DFF40/CAD in the chromatin fraction to promote oligo-
nucleosomal DNA degradation during apoptotic cell death.
The caspase-dependent accumulation of the endonuclease in
this fraction relies on a cytosolic pool that is translocated to the
nucleus upon apoptotic stimuli. DFF40/CAD is required to be
present in the cytosol because of the preferential processing of
DFF45/ICADL in this subcellular compartment.
DISCUSSION
It is well accepted that apoptosis is a biological consequence
of a series of complex biochemical and cellular events. Regard-
less of the specific intracellular pathway activated, apoptosis is
depicted morphologically by condensation (highly packaged
chromatin, or pyknosis) and fragmentation of the nuclei (kary-
orrhexis) (also known as stage II) and biochemically by oligo-
nucleosomal DNA degradation (also known as “DNA ladder-
ing”) (37, 38). These phenomena are accepted as the hallmarks
of apoptotic cell death. These two events have been tradition-
ally considered to occur concomitantly (1, 2, 30, 39). In this
work we establish that STP provokes different cell death fea-
tures, clearly distinguishable among eight different humanneu-
roblastoma-derived cell lines. We describe a set of cell lines
displaying a non-classical type of apoptotic nuclear morphol-
ogy upon STP treatment that corresponds with that previously
described as stage I (partial condensation of the chromatin
around the nuclear membrane) (40). The presence of this apo-
ptotic nuclear phenotype always correlates with an absence of a
DNA laddering pattern, which has been previously reported for
IMR-5 and IMR-32 cells (27, 30), and is now extended to
LAI-5S cells.We also show that the presence of stage II apopto-
tic nuclear morphology normally correlates with the ability of
the cell to achieve oligonucleosomal DNA degradation. How-
ever, despite sharing stage II nuclear morphology, SK-N-AS
was the only cell line unable to disintegrate its chromatin into
LMW size fragments. Although examples have already been
reported of cells displaying apoptotic nuclear morphology in
the absence of oligonucleosomal DNA degradation during cell
death (36, 41, 42), the role of DFF40/CAD in this cellular para-
digm has not been addressed yet.
The existence of a such cellular model could be a valuable
tool to discern how cells control the final steps of apoptotic cell
death. Indeed, we have taken advantage of SK-N-AS cell innate
behavior to understand why endogenous expression of DFF40/
CAD as well as ICAD processing are not enough to generate
DNA laddering in an intracellular environment in which stage
II apoptotic nuclear morphology occurs. Comparative bio-
chemical approaches between SK-N-AS cells and a cellular
model that undergoes a complete apoptotic phenotype upon
STP treatment, such as SH-SY5Y cells (27, 30, 31), allow us to
observe a dissimilar subcellular distribution of DFF40/CAD. In
fact, although SH-SY5Y cells show both cytosolic and nuclear
pools, in SK-N-AS cells the endonuclease is barely detected in
the cytosolic fraction. The subcellular localization of DFF40/
CAD remains controversial as data reported in the bibliography
seem to be contradictory. On the one hand, several laboratories
establish that DFF40/CAD is exclusively located in the cytosol
of the cells, translocating to the nucleus after caspase-mediated
ICAD processing (10, 18). On the other hand, other authors
indicate a nuclear localization of DFF40/CAD in proliferating
healthy cells, and therefore, further translocation to the nucleus
is not needed during apoptosis (12, 19–22). These data, which
seem to be contradictory, can be explained by the results pre-
sented in this work, establishing that the subcellular localiza-
tion of endogenous DFF40/CAD happens in a cell-specific
manner. In addition, we establish for the first time that the
DFF40/CAD subcellular distribution will condition the capa-
bility of a cell to die while degrading or not its chromatin into
oligonucleosomal fragments. We show here that this biochem-
ical apoptotic feature seems to be directly correlated with the
amount of DFF40/CAD protein content present in the cytosol.
Accordingly, the analysis of both total and cytosolic DFF40/
CAD protein content across the different human-derived neu-
roblastoma cell lines shows a direct correlation between the
cytosolic, but not the total, levels and the ability of the cell to
generate DNA laddering after STP treatment (supplemental
Fig. S3). In this regard SK-N-AS cells are able to degrade their
chromatin into LMW fragments once the cytosolic pool is
enhanced after exogenous expression of its own endonuclease.
The preferential processing of ICADL/S in the cytosol explains
the requirement for a cell to express the adequate amounts of
DFF40/CAD in the same subcellular compartment, leading to
DNA degradation into LMW fragments during apoptosis.
Along the same line, the activation of, at least, caspase-3 is nec-
essary for the proper cleavage of ICADL/S. Indeed, the release of
FIGURE 9. The translocationofDFF40/CAD from the cytosolic to the chro-
matin-enriched fraction is due to a preferential processing of ICADL/S in
the cytosol. SK-N-AS (SK) and SH-SY5Y (SH) cells were treated () or not ()
with 1M STP for 6 h. Then cells were fractionated to obtain the cytosolic (C),
the nucleoplasmic (N1), and the chromatin-enriched (N2) fractions, and
caspase-3 and ICAD cleavage were analyzed by Western blot. PKM2 and
topoisomerase I (TOPO I) were run as cytosolic and nuclear protein markers,
respectively.
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a caspase-3-mediated p11 C-terminal fragment from ICADL is
required for apoptotic nuclease activity (35). In this regard the
main processing of pro-caspase-3 takes place in the cytosol of
both cells lines analyzed even if caspase-3 active fragments can
also be evidenced in the nuclear fractions after STP treatment.
However, nuclear ICAD-CAD complex does not seem to be
affected, maybe because it is not reached by the limited
amounts of active caspase-3 detected in the nuclear fractions.
In the case of SK-N-AS cells, the cleaved ICAD in the cytoplasm
only liberates a small pool of CAD, due to the low cytosolic
levels.
Despite our findings, we cannot rule out the possibility of
other cellular paradigms in which the activation of the caspase-
3/ICAD/CAD axis occurs in other subcellular compartments
than in the cytosol. In these cases we can hypothesize that if
CAD protein levels are adequate, the cell should be able to
degrade its chromatin into oligonucleosome-size fragments
upon apoptotic insult. Therefore, the limiting aspect for the
occurrence of internucleosomal apoptotic DNA degradation
should be directly related to the levels of mature caspase-3,
rather than pro-caspase-3, afforded at the same subcellular
compartment in which ICAD-CAD complex resides. Then, in
healthy cells, the subcellular localization of pro-caspase-3 and
ICAD-CAD complex could be different without affecting the
capacity to degrade their chromatin into LMW fragments dur-
ing apoptosis. In this regard, it has been recently stated that
nuclear localization of active caspase-3, but not pro-caspase-3,
is closely related to the occupancy of its p3 recognition site,
located in the large subunit, possibly by an as yet unknown
non-degradable substrate (43).
Based on the last recommendations formulated by the
Nomenclature Committee on Cell Death (44), STP-induced
cell death in SK-N-AS cells as well as in SH-SY5Y cells can be
biochemically grouped into the “caspase-dependent intrinsic
apoptosis” category. However, from a classical point of view,
whereas SH-SY5Y cells undergo typical apoptosis, SK-N-AS
cells show an atypical apoptotic cell death characterized by an
incomplete degradation of their chromatin. There are many
examples in the literature of cells displaying atypical apoptotic
cell death that can be classified as “caspase-dependent intrinsic
apoptosis.” These cell types include the human acute lympho-
blastic leukemia cell line MOLT-4 (42), the human breast car-
cinoma-derived cell line MCF-7 (45), the human androgen-in-
dependent prostatic cancer cell DU-145 (41), the human
neuronal-like cell NT2 (46), and some human neuroblastoma-
derived cell lines such as IMR-5 and IMR-32 (27, 30). There-
fore, a cell committed to death can die despite occasional and
non-critical alterations in the intracellular pathway triggered.
For example, when caspase-3-defective MCF-7 cells die, they
activate the canonical intracellular apoptotic pathway bypass-
ing the absence of caspase-3 (45). Hence, the presence of
caspase-3 should be dispensable for cell death regardless of the
apoptotic inducer employed. However, the biological implica-
tions concerning caspase-3 activation are far from irrelevant
when considering an entire cellular population. Indeed, the
activation of caspase-3 during anti-cancer radiotherapy
prompts tumor cell repopulation (47). Similar to the caspase-3
example, oligonucleosomal DNA degradation is also consid-
ered a dispensable biochemical feature for the cell death of a
single cell or even for awell limited groupof cells (48).However,
the ability of a certain pool of cells to degrade their chromatin
into LMW-size fragments or not could entail disparate biolog-
ical consequences for their neighbors. In this regard, although
the information is limited concerning the cell death process in
the absence of oligonucleosomal DNA fragmentation, it is con-
sidered that chromatin degradation into LMW fragments con-
fers some advantages to the organism. For example, DNA deg-
radation may minimize the risk of transfer of non-degraded
cellular or viral DNA carrying potential oncogenes from a
doomed to an adjacent healthy cell (49–51). Moreover, it has
also been proposed that intact circulating nucleosomes in
blood from non- or partially degraded nuclear chromatin could
trigger some autoimmune diseases, such as systemic lupus ery-
thematosus, in which autoantibodies against heterochromatin
are generated (52). Finally, it is thought that phagocytic activity
of healthy neighboring cells can be facilitated if the chromatin
of apoptotic bodies is already fragmented (53). So the impor-
tance of revealing the molecular mechanisms regulating the
final apoptotic steps, such as DNA degradation into oligo-
nucleosomal pieces, resides in the biological consequences for
neighboring cells. The identification of other cellular models,
including primary tumors as well as non-tumor cells, emulating
SK-N-AS cell behavior might be a valuable tool to detect new
critical points affecting downstream apoptotic signals, i.e. oli-
gonucleosomal DNA fragmentation. Therefore, knowledge of
the molecular mechanisms governing the full activation of
DFF40/CADmight be crucial for improving current therapeu-
tic approaches in diseases concerning DNA degradation, e.g.
cancer or autoimmune disorders.
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Iglesias-Guimarais et al., SUPPLEMENTAL DATA 
 
 
SUPPLEMENTAL FIGURE LEGENDS 
 
FIGURE S1. SK-N-AS cells are unable to degrade DNA in LMW fragments upon 
different stimuli that activate the intrinsic apoptotic pathway. SK-N-AS and SH-SY5Y cells 
were left untreated (Control) or treated for 48 or 72 hours, respectively, with different apoptotic 
stimuli: camptothecin (CPT), nocodazole (Ncdz) or paclitaxel (PTX) at the concentrations 
indicated in A. DNA was extracted and analyzed by conventional agarose gel electrophoresis 
and subsequent ethidium bromide staining (A). Alternatively, nuclei were stained with Hoechst 
33258 and cell death quantification was performed by counting type II nuclear morphology 
according to the Experimental procedures section (C). B, representative images showing the 
morphological appearance of the nuclei stained with Hoechst 33258 of SK-N-AS and SH-SY5Y 
cells treated or not with the different apoptotic stimuli employed. The corner panels are higher 
magnifications of the cells framed in the pictures. The bars indicate 40 µm. 
 
FIGURE S2. SK-N-AS cells are unable to degrade DNA in LMW fragments upon 
different stimuli that activate the extrinsic apoptotic pathway. SK-N-AS cells were left 
untreated (Control) or co-treated with activators of different death receptors and 5 µg/ml 
cycloheximide (CHX). The inducers employed were 100 ng/ml TNFα for 24 hours, 200 ng/ml 
anti-Fas antibody (CH11) for 48 hours or 50 ng/ml TRAIL for 24 hours. DNA was extracted 
and analyzed by conventional agarose gel electrophoresis and subsequent ethidium bromide 
staining. SH-SY5Y cells treated with 1 µM STP for 24 hours were used as a positive control of 
DNA laddering (A). Alternatively, nuclei were stained with Hoechst 33258 and cell death 
quantification was performed by counting type II nuclear morphology according to the 
Experimental procedures section (C). B, representative images showing the morphological 
appearance of the nuclei stained with Hoechst 33258 of SK-N-AS cells treated or not with the 
different apoptotic stimuli employed. The corner panels are higher magnifications of the cells 
framed in the pictures. The bars indicate 40 µm. 
 
FIGURE S3. DFF40/CAD expression in different human neuroblastoma-derived cell lines. 
Total (A) or cytosolic (B) extracts were obtained from eight different neuroblastoma cell lines 
(SK-N-SH, SH-SY5Y, LAN-1, SK-N-BE(2), SK-N-AS, IMR-5, IMR-32 and LAI-5S) and 
DFF40/CAD detection was performed by Western blot. The membranes were stained with 
Naphtol Blue (NB) to assess equal loading.   
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